Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
  1. Veracyte

    World Rank (Aug-2026)
    4,732
    Market Cap (Aug-2026)
    3.316 Billion USD
    World Rank (Jan-05-2024)
    5,873
    Market Cap (Jan-05-2024)
    1.898 Billion USD
    World Rank (Jul-30-2023)
    5,673
    Market Cap (Jul-30-2023)
    2.035 Billion USD
    World Rank (Dec-25-2022)
    5,892
    Market Cap (Dec-25-2022)
    1.764 Billion USD
    World Rank (Jan-07-2022)
    5,608
    Market Cap (Jan-07-2022)
    2.39 Billion USD
    Annual Revenue in USD
    517 Million USD
    Annual Operating Income in USD
    58 Million USD
    Annual Net Income in USD
    66 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Veracyte is a Pioneering Genomic Diagnostics company. It's innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis. The headquarters is in USA.
  2. Celldex Therapeutics

    World Rank (Aug-2026)
    4,755
    Market Cap (Aug-2026)
    3.294 Billion USD
    World Rank (Jan-05-2024)
    5,438
    Market Cap (Jan-05-2024)
    2.151 Billion USD
    World Rank (Jul-30-2023)
    6,490
    Market Cap (Jul-30-2023)
    1.640 Billion USD
    World Rank (Dec-25-2022)
    5,323
    Market Cap (Dec-25-2022)
    2.078 Billion USD
    World Rank (Jan-07-2022)
    6,911
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -287 Million USD
    Annual Net Income in USD
    -259 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Its pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Headquarters is in USA.

  3. Arcutis Biotherapeutics Inc.

    World Rank (Aug-2026)
    4,757
    Market Cap (Aug-2026)
    3.292 Billion USD
    World Rank (Jan-05-2024)
    14,287
    Market Cap (Jan-05-2024)
    0.381 Billion USD
    World Rank (Jul-30-2023)
    10,942
    Market Cap (Jul-30-2023)
    0.667 Billion USD
    World Rank (Dec-25-2022)
    9,104
    Market Cap (Dec-25-2022)
    0.871 Billion USD
    World Rank (Jan-07-2022)
    9,768
    Market Cap (Jan-07-2022)
    0.94 Billion USD
    Annual Revenue in USD
    372 Million USD
    Annual Operating Income in USD
    -12 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Arcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having  29 employees as on 2019. The headquarters is in USA.
  4. Cosmos Pharmaceutical Corporation

    World Rank (Aug-2026)
    4,758
    Market Cap (Aug-2026)
    3.291 Billion USD
    World Rank (Jan-05-2024)
    3,269
    Market Cap (Jan-05-2024)
    4.361 Billion USD
    World Rank (Jul-30-2023)
    3,204
    Market Cap (Jul-30-2023)
    4.578 Billion USD
    World Rank (Dec-25-2022)
    3,149
    Market Cap (Dec-25-2022)
    4.220 Billion USD
    World Rank (Jan-07-2022)
    2,987
    Market Cap (Jan-07-2022)
    5.62 Billion USD
    Annual Revenue in USD
    5,512 Million USD
    Annual Net Income in USD
    169 Million USD
    Annual Results for Period Ending
    MAY-2022 ending year
    Headquarters Country
    Company Profile

    Cosmo Pharmaceutical is a pharmaceutical company with a specialized focus on gastroenterology and endoscopy.

    Headquarters is in Japan.

    Cosmo Pharmaceutical has 234 employees as on December 2019.

    As on 2019, Annual Revenues is 62.49 Million EUR and Net Loss after taxes is 24.49 Million EUR.

    As on Mar-2022, COSMOS PHARMACEUTICAL CORPORATION has 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions.

  5. Wockhardt

    World Rank (Aug-2026)
    4,771
    Market Cap (Aug-2026)
    3.279 Billion USD
    World Rank (Jan-05-2024)
    9,498
    Market Cap (Jan-05-2024)
    0.844 Billion USD
    World Rank (Jul-30-2023)
    13,821
    Market Cap (Jul-30-2023)
    0.422 Billion USD
    World Rank (Dec-25-2022)
    13,972
    Market Cap (Dec-25-2022)
    0.394 Billion USD
    World Rank (Jan-07-2022)
    12,037
    Market Cap (Jan-07-2022)
    0.63 Billion USD
    Annual Revenue in USD
    402 Million USD
    Annual Net Income in USD
    -31 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
  6. Myovant Sciences

    World Rank (Aug-2026)
    4,776
    World Rank (Jan-05-2024)
    4,776
    World Rank (Jul-30-2023)
    4,776
    Market Cap (Jul-30-2023)
    2.620 Billion USD
    World Rank (Dec-25-2022)
    4,545
    Market Cap (Dec-25-2022)
    2.608 Billion USD
    World Rank (Jan-07-2022)
    8,121
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile

    Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.

    Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.

  7. Synthorx

    World Rank (Aug-2026)
    4,777
    World Rank (Jan-05-2024)
    4,777
    World Rank (Jul-30-2023)
    4,777
    World Rank (Dec-25-2022)
    4,777
    World Rank (Jan-07-2022)
    4,777
    Headquarters Country
    Company Profile

    Synthorx is a Clinical Stage Biotechnology company. It is focused on prolonging and improving the lives of people with cancer and autoimmune disorders and platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics referred to as Synthorins. The headquarters is in USA.

    Assore delisted from JSE in March-2020.

  8. Medacta Group SA

    World Rank (Aug-2026)
    4,832
    Market Cap (Aug-2026)
    3.212 Billion USD
    World Rank (Jan-05-2024)
    4,497
    Market Cap (Jan-05-2024)
    2.902 Billion USD
    World Rank (Jul-30-2023)
    4,525
    Market Cap (Jul-30-2023)
    2.852 Billion USD
    World Rank (Dec-25-2022)
    5,221
    Market Cap (Dec-25-2022)
    2.139 Billion USD
    World Rank (Jan-07-2022)
    4,944
    Market Cap (Jan-07-2022)
    2.92 Billion USD
    Annual Revenue in USD
    482 Million USD
    Annual Operating Income in USD
    67 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Medacta Group SA is an international company specialized in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques for joint replacement, spine surgery and sports medicine. The company annual revenue is 302.4 million EUR, annual net income is 37 million EUR and total assets are 441.9 million EUR as on 2020. The headquarters is in Switzerland.
  9. Pulse Biosciences

    World Rank (Aug-2026)
    4,870
    Market Cap (Aug-2026)
    3.177 Billion USD
    World Rank (Jan-05-2024)
    11,984
    Market Cap (Jan-05-2024)
    0.555 Billion USD
    World Rank (Jul-30-2023)
    13,911
    Market Cap (Jul-30-2023)
    0.416 Billion USD
    World Rank (Dec-25-2022)
    21,978
    Market Cap (Dec-25-2022)
    0.094 Billion USD
    World Rank (Jan-07-2022)
    14,855
    Market Cap (Jan-07-2022)
    0.40 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -77 Million USD
    Annual Net Income in USD
    -73 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Pulse Biosciences is a Novel Bioelectric Medicine company committed to health innovation that has the potential to improve and extend the lives of patients. It have 112 issued patents globally owned and licensed. The company annual revenue is 343.5 million USD and 82 employees as on 2020. The headquarters is in USA.
  10. Ambu A/S

    World Rank (Aug-2026)
    4,882
    Market Cap (Aug-2026)
    3.165 Billion USD
    World Rank (Jan-05-2024)
    3,461
    Market Cap (Jan-05-2024)
    4.058 Billion USD
    World Rank (Jul-30-2023)
    3,492
    Market Cap (Jul-30-2023)
    4.052 Billion USD
    World Rank (Dec-25-2022)
    3,888
    Market Cap (Dec-25-2022)
    3.219 Billion USD
    World Rank (Jan-07-2022)
    2,776
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    657 Million USD
    Annual Operating Income in USD
    18 Million USD
    Annual Net Income in USD
    14 Million USD
    Annual Results for Period Ending
    Sep-2022 ending year
    Headquarters Country
    Company Profile
    Ambu A/S is medical equipment manufacturing company with headquarters is in Copenhagen, Denmark.

Share

Ads